Combination Therapy Improved Chemoresistance in Ovarian Cancer

News   Nov 04, 2016

 
Combination Therapy Improved Chemoresistance in Ovarian Cancer
 
 
 

RELATED ARTICLES

Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

READ MORE

New Simple Test Could Help Cystic Fibrosis Patients Find Best Treatment

News

In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique shows promise as a fast, inexpensive indicator to help more patients access new treatments.

READ MORE

Cancer Cells Prevent Immune Cells from Producing Cancer Killing Chemicals

News

Researchers have identified a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE